Rapamycin resistance tied to defective regulation of p27Kip1
- PMID: 8943329
- PMCID: PMC231677
- DOI: 10.1128/MCB.16.12.6744
Rapamycin resistance tied to defective regulation of p27Kip1
Abstract
The potent antiproliferative activity of the macrolide antibiotic rapamycin is known to involve binding of the drug to its cytosolic receptor, FKBP12, and subsequent interaction with targets of rapamycin, resulting in inhibition of p70 S6 kinase (p70S6K). However, the downstream events that lead to inhibition of cell cycle progression remain to be elucidated. The antiproliferative effects of rapamycin are associated with prevention of mitogen-induced downregulation of the cyclin-dependent kinase inhibitor p27Kip1, suggesting that the latter may play an important role in the growth pathway targeted by rapamycin. Murine BC3H1 cells, selected for resistance to growth inhibition by rapamycin, exhibited an intact p70S6K pathway but had abnormally low p27 levels that were no longer responsive to mitogens or rapamycin. Fibroblasts and T lymphocytes from mice with a targeted disruption of the p27Kip1 gene had impaired growth-inhibitory responses to rapamycin. These results suggest that the ability to regulate p27Kip1 levels is important for rapamycin to exert its antiproliferative effects.
Similar articles
-
The upregulation of p27Kip1 by rapamycin results in G1 arrest in exponentially growing T-cell lines.Blood. 1998 Jan 15;91(2):561-9. Blood. 1998. PMID: 9427710
-
Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin.Nature. 1994 Dec 8;372(6506):570-3. doi: 10.1038/372570a0. Nature. 1994. PMID: 7990932
-
Rapamycin dissociates p70(S6K) activation from DNA synthesis stimulated by bombesin and insulin in Swiss 3T3 cells.J Biol Chem. 1997 Jan 24;272(4):2509-14. doi: 10.1074/jbc.272.4.2509. J Biol Chem. 1997. PMID: 8999966
-
Mechanism of action of the immunosuppressant rapamycin.Life Sci. 1996;58(5):373-95. doi: 10.1016/0024-3205(95)02233-3. Life Sci. 1996. PMID: 8594303 Review.
-
Mechanism of action of rapamycin (Sirolimus, Rapamune).Transplant Proc. 1996 Apr;28(2):964-9. Transplant Proc. 1996. PMID: 8623482 Review. No abstract available.
Cited by
-
Early loss of mammalian target of rapamycin complex 1 (mTORC1) signalling and reduction in cell size during dominant-negative suppression of hepatic nuclear factor 1-alpha (HNF1A) function in INS-1 insulinoma cells.Diabetologia. 2009 Jan;52(1):136-44. doi: 10.1007/s00125-008-1168-8. Epub 2008 Oct 24. Diabetologia. 2009. PMID: 18949455
-
Vascular smooth muscle cell proliferation in restenosis.Circ Cardiovasc Interv. 2011 Feb 1;4(1):104-11. doi: 10.1161/CIRCINTERVENTIONS.110.957332. Circ Cardiovasc Interv. 2011. PMID: 21325199 Free PMC article. Review. No abstract available.
-
Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury.Circulation. 2010 Feb 2;121(4):537-48. doi: 10.1161/CIRCULATIONAHA.109.887695. Epub 2010 Jan 18. Circulation. 2010. PMID: 20083679 Free PMC article.
-
Deptor knockdown enhances mTOR Activity and protein synthesis in myocytes and ameliorates disuse muscle atrophy.Mol Med. 2011 Sep-Oct;17(9-10):925-36. doi: 10.2119/molmed.2011.00070. Epub 2011 May 19. Mol Med. 2011. PMID: 21607293 Free PMC article.
-
A novel role for ATR/Rad3 in G1 phase.Sci Rep. 2018 May 2;8(1):6880. doi: 10.1038/s41598-018-25238-6. Sci Rep. 2018. PMID: 29720710 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical